Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis
With this review, we provide the state of the art concerning brain metastases (BMs) from ovarian cancer (OC), a rare condition. Clinical, pathological, and molecular features, treatment options, and future perspectives are comprehensively discussed. Overall, a diagnosis of high-grade serous OC and a...
Main Authors: | Fulvio Borella, Luca Bertero, Antonio Morrone, Alessandro Gambella, Marialuisa Bovetti, Stefano Cosma, Andrea Carosso, Dionyssios Katsaros, Silvia Gemmiti, Mario Preti, Giorgio Valabrega, Giulia Scotto, Paola Cassoni, Chiara Benedetto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2156 |
Similar Items
-
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
by: Gloria Mittica, et al.
Published: (2020-05-01) -
Orbital Metastases from Breast Cancer with BRCA2 Mutation: A Case Report and Literature Review
by: Emily Barber, et al.
Published: (2018-06-01) -
Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
by: Fulvio Borella, et al.
Published: (2020-03-01) -
Niraparib as Maintenance Therapy in Germline ATM-mutated and Somatic BRCA2-mutated Ovarian Cancer with Brain Metastases: A Case Report and Literature Review
by: Tao M, et al.
Published: (2020-12-01) -
Ovarian carcinoma in patients with BRCA mutation - a correlation between the growing pattern of peritoneal implants evaluated by CT/MRI and the genotype BRCA1 and BRCA2
by: Ana Catarina Vieira, et al.
Published: (2020-04-01)